PARATEK PHARMACEUTICALS

Lobbying client. Federal LDA filings.

Connected on the graph

Inbound (10)

date	from	type	amount	source
—	John Scofield	lobbied_for	—	lda_lobbyist_client
—	Benjamin Novak	lobbied_for	—	lda_lobbyist_client
—	Martin Delgado	lobbied_for	—	lda_lobbyist_client
—	Jose Ceballos	lobbied_for	—	lda_lobbyist_client
—	Chanda Betourney	lobbied_for	—	lda_lobbyist_client
2026-01-01	S-3 GROUP	lobbies_for	$50,000	lda_filing
2026-01-01	PARATEK PHARMACEUTICALS	lobbies_for	$20,000	lda_filing
2026-01-01	S-3 GROUP	lobbies_for	$50,000	lda_filing
2025-01-01	PARATEK PHARMACEUTICALS	lobbies_for	$10,000	lda_filing
2025-01-01	PARATEK PHARMACEUTICALS	lobbies_for	—	lda_filing

Source id: 63708
General description: Biopharmaceutical company
State: PA
Country: US
Principal place of business: US
Effective date: 2024-12-01
Total spend (across 2 ingested filings): $100,000

Filings

Posted	Type	Year	Lobbying firm	Income
2026-04-17	`Q1`	2026	S-3 GROUP	$50,000
2026-04-17	`Q1`	2026	S-3 GROUP	$50,000

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.